The American Journal of Managed Care

Lung Cancer Molecular Testing Nears 70%, Still Falls Short of Universal Use: Christopher D'Avella, MD

Reflex molecular testing and nurse navigation cut delays in lung cancer care, helping more patients get targeted results ...
PharmiWeb

Molecular Infectious Disease Testing Market: Growth, Innovations, and Opportunities

Global Molecular Infectious Disease Testing Market OverviewThe global Molecular Infectious Disease Testing Market encompasses ...

New molecular tests to change how TB is detected?

Latest platforms from Indian and Chinese cos eliminate need for sputum and use tongue swabs for testing ...
Business Wire

New Study Shows Longhorn Vaccines and Diagnostics’ PrimeStore Molecular Transport Medium Improves Tuberculosis Testing in Children

BETHESDA, Md. & GAITHERSBURG, Md.--(BUSINESS WIRE)--Longhorn Vaccines and Diagnostics LLC, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, ...
ascopubs.org

Improving Time to Molecular Testing Results in Patients With Newly Diagnosed, Metastatic Non–Small-Cell Lung Cancer

We reviewed electronic medical records of patients with newly diagnosed, untreated metastatic NSCLC from December 2018 to August 2021 and determined the number of days from pathologic diagnosis to NGS ...

Molecular test for bile duct cancer nearly doubles detection rate

When patients develop a narrowing or blockage in the bile ducts—the tubes connecting the liver, gallbladder and ...
EurekAlert!

Molecular testing of FLT3 mutations in hematolymphoid malignancies in the era of next-generation sequencing

The illustration of protein structure (domains) on the left side, and corresponding exons in the FLT3 gene are displayed on the right side. FMS-like tyrosine kinase 3 (FLT3) mutations represent some ...

Molecular Diagnostics Market Size Is Expected To Reach USD 43.50 Billion By 2035 Owing To The Surging Demand For Accurate And Early Disease Detection Globally SNS Insider

Molecular Diagnostics Market Size Is Expected To Reach USD 43.50 Billion By 2035 Owing To The Surging Demand For Accurate And Early Disease Detection Globally SNS Insider. U.S. Molecular Diagnostics ...